147 related articles for article (PubMed ID: 19920765)
1. Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice.
Van Tassell BW; Varma A; Salloum FN; Das A; Seropian IM; Toldo S; Smithson L; Hoke NN; Chau VQ; Robati R; Abbate A
J Cardiovasc Pharmacol; 2010 Feb; 55(2):117-22. PubMed ID: 19920765
[TBL] [Abstract][Full Text] [Related]
2. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.
Abbate A; Salloum FN; Vecile E; Das A; Hoke NN; Straino S; Biondi-Zoccai GG; Houser JE; Qureshi IZ; Ownby ED; Gustini E; Biasucci LM; Severino A; Capogrossi MC; Vetrovec GW; Crea F; Baldi A; Kukreja RC; Dobrina A
Circulation; 2008 May; 117(20):2670-83. PubMed ID: 18474815
[TBL] [Abstract][Full Text] [Related]
3. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
[TBL] [Abstract][Full Text] [Related]
5. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat.
Straino S; Salloum FN; Baldi A; Ockaili RA; Piro M; Das A; Qureshi IZ; Biasucci LM; Capogrossi MC; Biondi-Zoccai GG; Severino A; Mellone P; Crea F; Vetrovec GW; Kukreja RC; Abbate A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):571-7. PubMed ID: 18030068
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
[TBL] [Abstract][Full Text] [Related]
9. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
10. Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization.
Hu Y; Zhang H; Lu Y; Bai H; Xu Y; Zhu X; Zhou R; Ben J; Xu Y; Chen Q
Basic Res Cardiol; 2011 Nov; 106(6):1311-28. PubMed ID: 21769674
[TBL] [Abstract][Full Text] [Related]
11. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
[TBL] [Abstract][Full Text] [Related]
12. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction.
Ren J; Zhang S; Kovacs A; Wang Y; Muslin AJ
J Mol Cell Cardiol; 2005 Apr; 38(4):617-23. PubMed ID: 15808838
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic inhibition of phosphoinositide 3-kinase gamma (PI3Kγ) promotes infarct resorption and prevents adverse cardiac remodeling after myocardial infarction in mice.
Seropian IM; Abbate A; Toldo S; Harrington J; Smithson L; Ockaili R; Mezzaroma E; Damilano F; Hirsch E; Van Tassell BW
J Cardiovasc Pharmacol; 2010 Dec; 56(6):651-8. PubMed ID: 20881611
[TBL] [Abstract][Full Text] [Related]
14. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
[TBL] [Abstract][Full Text] [Related]
15. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.
Maekawa Y; Mizue N; Chan A; Shi Y; Liu Y; Dawood S; Chen M; Dawood F; de Couto G; Li GH; Suzuki N; Yeh WC; Gramolini A; Medin JA; Liu PP
Circulation; 2009 Oct; 120(14):1401-14. PubMed ID: 19770394
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
Abbate A; Kontos MC; Grizzard JD; Biondi-Zoccai GG; Van Tassell BW; Robati R; Roach LM; Arena RA; Roberts CS; Varma A; Gelwix CC; Salloum FN; Hastillo A; Dinarello CA; Vetrovec GW;
Am J Cardiol; 2010 May; 105(10):1371-1377.e1. PubMed ID: 20451681
[TBL] [Abstract][Full Text] [Related]
17. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
Shishido T; Nozaki N; Yamaguchi S; Shibata Y; Nitobe J; Miyamoto T; Takahashi H; Arimoto T; Maeda K; Yamakawa M; Takeuchi O; Akira S; Takeishi Y; Kubota I
Circulation; 2003 Dec; 108(23):2905-10. PubMed ID: 14656915
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
Zaidi SH; Huang Q; Momen A; Riazi A; Husain M
J Am Coll Cardiol; 2010 Jan; 55(2):135-43. PubMed ID: 20117381
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
